MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

MPR Drug News

Clinicians' Attitudes Towards E-Cigarette Use for Smoking Cessation

A recent survey found that a substantial number of clinicians believe e-cigarettes can help patients reduce or stop smoking, with 37.9% stating they having recommended e-cigarettes to patients who smoke.

CDC: Updated Influenza Vaccine Recommendations Released

Here are the changes for the 2016-2017 flu season.

Some Good News for Cheese Lovers

A new study published in The American Journal of Clinical Nutrition found that regular-fat cheese consumption, compared to reduced-fat cheese or an isocaloric amount of carbohydrate-rich foods, did not change LDL cholesterol levels and metabolic syndrome risk factors.

Efficacy of Platelet Inhibitors Compared in Diabetes Patients with CAD

In patients with diabetes mellitus with coronary artery disease, ticagrelor provided similar or greater inhibition of ADP-induced platelet reactivity vs. prasugrel in the acute and chronic phases of treatment, an article in Circulation reported.

Synacthen Depot Fast-Tracked for Duchenne Muscular Dystrophy

Mallinckrodt announced that the FDA has granted Fast Track designation to the Investigational New Drug (IND) application of Synacthen Depot (tetracosactide) for the treatment of Duchenne muscular dystrophy (DMD).